Review





Similar Products

96
Proteintech antibodies targeting m6a
Antibodies Targeting M6a, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies targeting m6a/product/Proteintech
Average 96 stars, based on 1 article reviews
antibodies targeting m6a - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

92
Novus Biologicals anti m 6 a antibody
Anti M 6 A Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti m 6 a antibody/product/Novus Biologicals
Average 92 stars, based on 1 article reviews
anti m 6 a antibody - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier

86
Cell Signaling Technology Inc anti m6a antibody
Loss of METTL14 alters <t>m6A</t> modification, leading to mitochondrial dysfunction, cGAS-STING-IFN-I activation, and necroptosis. These parallel pathways converge to drive cardiomyopathy and heart failure.
Anti M6a Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti m6a antibody/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
anti m6a antibody - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

96
Proteintech anti m6a antibody
NEU1 mRNA stability is regulated by <t>m6A</t> modification. (A) Total m6A levels in RNA from mouse atrial tissues and atrial fibroblasts were measured using an m6A quantification kit. (B) Western blot analysis of METTL3 expression in atrial tissues and atrial fibroblasts. (C) RNA immunoprecipitation (RIP) assay confirming the interaction between NEU1 and METTL3 in atrial fibroblasts. (D) Western blot analysis of METTL3 expression in primary mouse atrial fibroblasts. (E) MeRIP-qPCR assay detecting the m6A modification level on NEU1 mRNA in primary mouse atrial fibroblasts. (F) NEU1 mRNA stability assessed by qPCR in atrial fibroblasts treated with actinomycin D at 0, 3, and 6 hours post-transfection with sh-NC or sh-METTL3.
Anti M6a Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti m6a antibody/product/Proteintech
Average 96 stars, based on 1 article reviews
anti m6a antibody - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

86
Cell Signaling Technology Inc anti m6a specific antibody
NEU1 mRNA stability is regulated by <t>m6A</t> modification. (A) Total m6A levels in RNA from mouse atrial tissues and atrial fibroblasts were measured using an m6A quantification kit. (B) Western blot analysis of METTL3 expression in atrial tissues and atrial fibroblasts. (C) RNA immunoprecipitation (RIP) assay confirming the interaction between NEU1 and METTL3 in atrial fibroblasts. (D) Western blot analysis of METTL3 expression in primary mouse atrial fibroblasts. (E) MeRIP-qPCR assay detecting the m6A modification level on NEU1 mRNA in primary mouse atrial fibroblasts. (F) NEU1 mRNA stability assessed by qPCR in atrial fibroblasts treated with actinomycin D at 0, 3, and 6 hours post-transfection with sh-NC or sh-METTL3.
Anti M6a Specific Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti m6a specific antibody/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
anti m6a specific antibody - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc monoclonal antibody
NEU1 mRNA stability is regulated by <t>m6A</t> modification. (A) Total m6A levels in RNA from mouse atrial tissues and atrial fibroblasts were measured using an m6A quantification kit. (B) Western blot analysis of METTL3 expression in atrial tissues and atrial fibroblasts. (C) RNA immunoprecipitation (RIP) assay confirming the interaction between NEU1 and METTL3 in atrial fibroblasts. (D) Western blot analysis of METTL3 expression in primary mouse atrial fibroblasts. (E) MeRIP-qPCR assay detecting the m6A modification level on NEU1 mRNA in primary mouse atrial fibroblasts. (F) NEU1 mRNA stability assessed by qPCR in atrial fibroblasts treated with actinomycin D at 0, 3, and 6 hours post-transfection with sh-NC or sh-METTL3.
Monoclonal Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal antibody/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
monoclonal antibody - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

96
Proteintech m6a
NEU1 mRNA stability is regulated by <t>m6A</t> modification. (A) Total m6A levels in RNA from mouse atrial tissues and atrial fibroblasts were measured using an m6A quantification kit. (B) Western blot analysis of METTL3 expression in atrial tissues and atrial fibroblasts. (C) RNA immunoprecipitation (RIP) assay confirming the interaction between NEU1 and METTL3 in atrial fibroblasts. (D) Western blot analysis of METTL3 expression in primary mouse atrial fibroblasts. (E) MeRIP-qPCR assay detecting the m6A modification level on NEU1 mRNA in primary mouse atrial fibroblasts. (F) NEU1 mRNA stability assessed by qPCR in atrial fibroblasts treated with actinomycin D at 0, 3, and 6 hours post-transfection with sh-NC or sh-METTL3.
M6a, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/m6a/product/Proteintech
Average 96 stars, based on 1 article reviews
m6a - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

Image Search Results


Loss of METTL14 alters m6A modification, leading to mitochondrial dysfunction, cGAS-STING-IFN-I activation, and necroptosis. These parallel pathways converge to drive cardiomyopathy and heart failure.

Journal: bioRxiv

Article Title: METTL14-dependent m 6 A modification restrains interferon signaling to prevent myocarditis and dilated Cardiomyopathy

doi: 10.64898/2026.04.02.716218

Figure Lengend Snippet: Loss of METTL14 alters m6A modification, leading to mitochondrial dysfunction, cGAS-STING-IFN-I activation, and necroptosis. These parallel pathways converge to drive cardiomyopathy and heart failure.

Article Snippet: Membranes were then blocked with 5% nonfat dry milk in 1× PBST for 1 h at room temperature and incubated overnight at 4 °C with an anti-m6A antibody (1:5,000; Cell Signaling Technology, Cat. #56593).

Techniques: Modification, Activation Assay

NEU1 mRNA stability is regulated by m6A modification. (A) Total m6A levels in RNA from mouse atrial tissues and atrial fibroblasts were measured using an m6A quantification kit. (B) Western blot analysis of METTL3 expression in atrial tissues and atrial fibroblasts. (C) RNA immunoprecipitation (RIP) assay confirming the interaction between NEU1 and METTL3 in atrial fibroblasts. (D) Western blot analysis of METTL3 expression in primary mouse atrial fibroblasts. (E) MeRIP-qPCR assay detecting the m6A modification level on NEU1 mRNA in primary mouse atrial fibroblasts. (F) NEU1 mRNA stability assessed by qPCR in atrial fibroblasts treated with actinomycin D at 0, 3, and 6 hours post-transfection with sh-NC or sh-METTL3.

Journal: Cell Adhesion & Migration

Article Title: N6-methyladenosine modification of NEU1 mediated by METTL3 exacerbates angiotensin II-induced atrial fibrillation

doi: 10.1080/19336918.2026.2650272

Figure Lengend Snippet: NEU1 mRNA stability is regulated by m6A modification. (A) Total m6A levels in RNA from mouse atrial tissues and atrial fibroblasts were measured using an m6A quantification kit. (B) Western blot analysis of METTL3 expression in atrial tissues and atrial fibroblasts. (C) RNA immunoprecipitation (RIP) assay confirming the interaction between NEU1 and METTL3 in atrial fibroblasts. (D) Western blot analysis of METTL3 expression in primary mouse atrial fibroblasts. (E) MeRIP-qPCR assay detecting the m6A modification level on NEU1 mRNA in primary mouse atrial fibroblasts. (F) NEU1 mRNA stability assessed by qPCR in atrial fibroblasts treated with actinomycin D at 0, 3, and 6 hours post-transfection with sh-NC or sh-METTL3.

Article Snippet: For each sample, 50 μg of fragmented RNA was reserved as input, and the remaining RNA was incubated with 5 μg of anti-m6A antibody (68055–1-Ig, Proteintech) or IgG antibody (30000–0-AP, Proteintech) at 4°C overnight with gentle rotation, followed by incubation with Protein A/G magnetic beads (88802, Thermo Fisher Scientific) for 2 hours at 4°C.

Techniques: Modification, Western Blot, Expressing, RNA Immunoprecipitation, Transfection